Tianjin Lisheng Pharmaceutical Co.,Ltd.’s Net Profit Rose 10.8% in First Quarter of 2023

Tianjin Lisheng Pharmaceutical Co.,Ltd. (天津力生制药股份有限公司) (002393.SZ) reported a net profit of 46.5 million yuan in the first quarter of 2023, up 10.8% year-on-year.

Meanwhile, the company posted 335.6 million yuan in revenue, up 9.5% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 945.6 million yuan in total liabilities, with a liability-to-asset ratio of 17.6%.